Status:
COMPLETED
Study of Three Alternatives for Mass Treatment in Trachoma Villages of Tanzania
Lead Sponsor:
Johns Hopkins University
Collaborating Sponsors:
International Trachoma Initiative
Conditions:
Trachoma
Eligibility:
All Genders
12-7 years
Phase:
PHASE4
Brief Summary
After single, yearly, mass treatment of communities with azithromycin for active trachoma, what is the added effectiveness for reduction of trachoma and ocular C. trachomatis infection at one, two, an...
Detailed Description
An important component of a trachoma control program is the effective use of antibiotics, particularly azithromycin, to reduce the pool of chlamydial ocular infection in the communities. A reduction i...
Eligibility Criteria
Inclusion
- villages not in the Tanzania National Trachoma control Program in Kongwa, Tanzania
- villages with population size less than 5,000
- sentinel children: ages 1 year to 7 years
Exclusion
- Village leadership refuses to allow village participation
- sentinel children: previous history of treatment with azithromycin
- sentinel children: another family member (child)already enrolled in study
Key Trial Info
Start Date :
April 1 2002
Trial Type :
INTERVENTIONAL
End Date :
November 1 2005
Estimated Enrollment :
2700 Patients enrolled
Trial Details
Trial ID
NCT00347607
Start Date
April 1 2002
End Date
November 1 2005
Last Update
October 28 2011
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
Johns Hopkins university
Baltimore, Maryland, United States, 21205
2
Kongwa Trachoma Project
Kongwa, Dodoma, Tanzania